ACADIA Pharmaceuticals Inc (ACAD)
22.26
-0.56 -2.45%
NASDAQ
Feb 21, 20:00
Delayed 2m
USD
View All Key Stats
ACAD Key Stats
| Income Statement | |
| Revenue (TTM) | 207.80M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -2.00 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -248.57M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 93.42% |
| Profit Margin (Quarterly) | -106.6% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 2.784B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 13.36 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 12.46 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -43.30M |
| Return on Equity (TTM) | Upgrade |
View All ACAD News
ACAD News
-
WireHeadlineTime (ET)
-
Business Wire02/21 09:00
-
Yahoo02/15 16:08
-
Yahoo02/14 12:58
-
Globe Newswire02/13 08:15
-
Business Wire02/12 09:00
-
Yahoo02/11 16:51
-
Yahoo02/11 15:58
-
Yahoo02/08 16:56
-
Yahoo02/08 08:07
-
Yahoo02/07 16:31
View All Events
ACAD Events
| Date | Type | Description |
|---|---|---|
| 02/27/2019 17:00 EST | Misc | ACADIA Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2018 |
| 02/27/2019 | Earnings | ACADIA Pharmaceuticals Inc Fourth Quarter Earnings in 2018 Release |
| 11/06/2018 17:00 EST | Misc | ACADIA Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2018 |
| 11/06/2018 | Earnings | ACADIA Pharmaceuticals Inc Third Quarter Earnings in 2018 Release |
| 08/08/2018 17:00 EDT | Misc | ACADIA Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2018 |
| 08/08/2018 | Earnings | ACADIA Pharmaceuticals Inc Second Quarter Earnings Results in 2018 |
| 06/06/2018 | Misc | ACADIA Pharmaceuticals Inc Annual General Meeting in 2017 |
| 05/04/2018 08:30 EDT | Misc | ACADIA Pharmaceuticals Inc First Quarter Earnings Conference Call in 2018 |
| 05/04/2018 | Earnings | ACADIA Pharmaceuticals Inc First Quarter Earnings Results in 2018 |
| 02/27/2018 17:00 EST | Misc | ACADIA Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2017 |
ACAD Fundamentals
Income Statement View Statement
ACAD Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
ACAD One Page Reports
- One Page Report Download
ACAD Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 22.26 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.acadia-pharm.com
- Investor Relations URL: http://ir.acadia-pharm.com/phoenix.zhtml?c=125180&p=irol-irhome
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Growth
- Next Earnings Release: Feb. 27, 2019
- Last Earnings Release: Nov. 06, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson’s, Alzheimer’s, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
ACAD Excel Add-In Codes
- Name: =YCI("ACAD","name")
- Description: =YCI("ACAD","description")
- Sector: =YCI("ACAD","sector")
- Industry: =YCI("ACAD","industry")
- Est. Current Fiscal Year End: =YCI("ACAD","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other ACAD Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ACAD Tweets Stocktwits
Advertisement
